Evaluation of sample rejection rate in clinical biochemistry laboratory before and after implementation of six-sigma methodology
DOI:
https://doi.org/10.3126/ajms.v14i2.43189Keywords:
Biochemistry laboratory; Six-sigma; Sample rejectionAbstract
Background: In pre-analytical phase of Clinical Biochemistry Laboratory, sample rejection is a very frequent and important source of error. It affects the overall quality of laboratory services and patient care by increasing cost and turnaround time. It leads to test abandonment and causes inconvenience to patients and staff.
Aims and Objectives: The aim of the study was to implement the define, measure, analyze, improve, and control (DMAIC) method of six-sigma to decrease the rate of sample rejection in Clinical Biochemistry Laboratory.
Materials and Methods: In this prospective study, sample rejection rates were analyzed in a clinical Biochemistry Laboratory before and after implementation of DMAIC method of six-sigma. Baseline rejection rates were calculated for a year and classified based on cause of rejection and patient location. Current defects per million opportunities and six sigma values were calculated. This was followed by root cause analysis and implementation of corrective and preventive measures. Reanalysis of the baseline measures was done to observe the impact of these measures.
Results: After implementation of DMAIC, the overall rejection rate fell from 1.07% to 0.49% with an increase in sigma value from 3.8 to 4.1.
Conclusion: Six-sigma tool like DMAIC can be successfully implemented to improve sample rejection rates ultimately improving the quality of laboratory services in resource limited setting with minimal financial implications.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Asian Journal of Medical Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- The journal holds copyright and publishes the work under a Creative Commons CC-BY-NC license that permits use, distribution and reprduction in any medium, provided the original work is properly cited and is not used for commercial purposes. The journal should be recognised as the original publisher of this work.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).